MCRB: SEC Form 8-K filed by Seres Therapeutics Inc.

Historical context for MCRB

Across the 21 sessions after earlier MCRB headlines, the stock closed higher 9 times and lower 12 times, with a median move of 3.2% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.

Keep researching MCRB

• What is Form 8-K?The SEC "current report" a public company files to disclose material events, generally within four business days of the event.
• Form 8-K explainedWhat a Form 8-K is, when it is due, and what each key item number means, from 1.01 material agreements and 2.02 earnings to 4.02 restatements and 5.02 executive changes.
• MCRB insider tradesEvery buy and sale reported by Seres Therapeutics Inc. officers, directors and large holders.
• MCRB earnings historyPast Seres Therapeutics Inc. earnings releases, newest first.
• MCRB financial statementsRevenue, profit, cash flow and balance sheet from Seres Therapeutics Inc.'s SEC filings.